That all changed over the past year with the approval of Yervoy™ and Zelboraf™. In this issue of The Melanoma Letter, Dr. Paul Chapman discusses the exciting, newly FDA-approved drug Zelboraf ...

Plexxikon had great expectations for Zelboraf when it first reached the market, pegging peak sales at around $700 million a year, but it never reached those heights with annual sales in the region ...

this infrastructure award supports a network of 18 adult centres (of excellence) and 11 paediatric locations throughout the UK. *****Combination treatments Cotellic + Zelboraf and Herceptin + Perjeta.

Sir Harpal mentions new targeted treatments such as Roche's skin cancer drug Zelboraf (vemurafenib) as an example, as it targets the BRAF V600 mutation present in some patients. "We hope that ...